Mitochondrial DNA replication during differentiation of murine embryonic stem cells by Facucho-Oliveira, J.M. et al.
4025Research Article
Introduction
Mitochondria are organelles responsible for the production of
the vast majority of ATP within eukaryotic cells. They contain
their own genome, mitochondrial DNA (mtDNA), which
encodes 13 of the 70+ subunits of the electron-transfer chain
(ETC), 22 transfer (t)RNAs and two ribosomal (r)RNAs
(Anderson et al., 1981). Mutation, deletion or depletion in one
or more of these genes can result in cellular impairment, or can
be lethal (Wallace, 1999).
MtDNA replication is reliant on nuclear-encoded
transcription and replication factors that are translocated to the
mitochondria (Clayton, 1998). Two key factors involved in
mtDNA replication are mitochondrial transcription factor A
(TFAM) and the mitochondrial-specific DNA polymerase
gamma (Clayton, 1982; Clayton, 1998). TFAM is a high
mobility group (HMG) protein that triggers mtDNA
transcription in mammals (Parisi and Clayton, 1991; Garstka
et al., 2003), which in turn results in generation of the RNA
primer necessary for the initiation of mtDNA replication
(Clayton, 1992; Xu and Clayton, 1995). Mammalian
polymerase gamma is a heterotrimer enzyme composed of one
catalytic subunit (POLG) and two accessory subunits
(POLG2) (Carrodeguas et al., 2001). The functions of POLG2
are to recognise the primer that initiates mtDNA replication
and to confer high fidelity polymerisation to POLG (Xu and
Clayton, 1996; Lim et al., 1999; Carrodeguas et al., 2001).
The importance of the onset of mtDNA transcription and
replication for embryo survival is demonstrated by both Polg
and Tfam homozygous knockout mice: either knockout
produces severe mtDNA depletion, respiratory-chain deficiency
and death prior to embryonic day (E)8.5 (Hance et al., 2005)
and 10.5 (Larsson et al., 1998), respectively. Because murine
oocytes possess 105 mtDNA copies immediately prior to
fertilisation and there is no increase in mtDNA copy number
until post-implantation, each newly divided blastomere within
the pre-implantation embryo will possess fewer copies of the
genome at each stage of post-fertilisation cell division
(Shoubridge and Wai, 2007). This persists until the blastocyst
(Thundathil et al., 2005), the final stage of pre-implantation
development. Consequently, undifferentiated human embryonic
stem cells (hESCs), derived from the inner cell mass of the
blastocyst, have very low numbers of mitochondria (Rivolta and
Holley, 2002; St John et al., 2005) and a high nuclear-to-
cytoplasmic ratio (Thomson et al., 1998). Differentiation of
hESCs results in the expansion of mitochondrial number (St
John et al., 2005), which is likely to be matched by increased
mtDNA copy number. This expansion supports the concept that
the metabolic demands of a specific cell type correlate with its
oxidative capacity, and therefore with the levels of mtDNA and
transcription for all the components of the ETC (Williams,
1986; Moyes et al., 1998). Consequently, successful
differentiation of ESCs will require lineage-specific
Oxidative phosphorylation (OXPHOS), the intracellular
process that generates the majority of the ATP of a cell
through the electron-transfer chain, is highly dependent on
proteins encoded by the mitochondrial genome (mtDNA).
MtDNA replication is regulated by the nuclear-encoded
mitochondrial transcription factor A (TFAM) and the
mitochondrial-specific DNA polymerase gamma, which
consists of a catalytic (POLG) and an accessory (POLG2)
subunit. Differentiation of pluripotent embryonic stem cells
(ESCs) into specific cell types requires expansion of discrete
populations of mitochondria and mtDNA replication to
meet the specific metabolic requirements of the cell. We
determined by real-time PCR that expression of
pluripotent markers is reduced before the upregulation of
Polg, Polg2 and Tfam in spontaneously differentiating R1
murine (m)ESCs, along with transient increases in mtDNA
copy number. In D3 mESCs, the initial transient increase
did not take place. However, precursors of neuronal and
cardiomyocyte differentiation were positive for both POLG
and TFAM. Similar-stage ESCs also showed active mtDNA
replication, identified by 5-bromo-2-deoxy-uridine
labelling, as mtDNA copy number increased. Retinoic-acid-
induced differentiation resulted in more consistent patterns
of replication and upregulation of Polg, Polg2 and Tfam,
whereas siRNA knockdown demonstrated that steady-
state expression of POLG is essential for maintaining
pluripotency.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/22/4025/DC1
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transcription in the nucleus, along with effective nucleo-
cytoplasmic coordination to balance mtDNA transcription and
replication with nuclear transcription of ETC subunits.
Retinoic acid (RA), a vitamin A derivative, is essential for
normal embryo development (Morriss-Kay and Sokolova,
1996) and induces cell-type-specific differentiation of ESCs
and embryonic carcinoma cells (ECCs) in a concentration- and
time-dependent manner (Dani et al., 1997; Drab et al., 1997;
Rohwedel et al., 1999). Exposure of murine (m)ESCs to 10–7-
10–6 M of RA in the early days of in vitro differentiation has
been shown to considerably enhance neurogenesis (Bain et al.,
1995; Strübing et al., 1995). Similar to the effect of RA on
nuclear genes regulating cell differentiation (Gottlieb and
Huettner, 1999), RA can bind to the RA-specific receptors
(RAR) present in the mitochondria (Berdanier et al., 2001),
activating the RA response elements (RARE) in the regulatory
region of the mtDNA (D-loop) (Wrutniak et al., 1995;
Demonacos et al., 1996), which, in turn, initiates mtDNA
transcription and replication during ESC differentiation.
The early stages of ESC differentiation are related to the loss
of pluripotency (Pesce and Schöler, 2001). Similar to the gene
encoding the pluripotency marker OCT4 (POU5F1), Pramel
(Prame-like) and Dppa (developmental pluripotency associated
genes) are expressed up to the epiblast stage of embryonic
development and in undifferentiated mESCs, but their
expression is not detected in somatic tissue (Bortvin et al.,
2003). Furthermore, it has recently been demonstrated that
mRNA expression for DPPA3 and DPPA5 is downregulated
during hESC differentiation (Lagarkova et al., 2006). In vitro
differentiation of mESCs gives rise to the three primary germ
layers – the endoderm, mesoderm and ectoderm – that
characterise early stages of embryonic development (Leahy et
al., 1999). This is then followed by the expression of stage-
specific markers, associated with certain lineages, such as
vimentin, nestin and -tubulin III during neuronal
differentiation (Rolletschek et al., 2001; Bouhon et al., 2006)
and brachyury during cardiac differentiation (Herrmann et al.,
1990; Wilkinson et al., 1990). There is some initial evidence
to suggest that POLG and TFAM are both expressed during
early hESC differentiation, as is OCT4 (St John et al., 2005).
However, it has not been demonstrated whether the initiation
of mtDNA replication precedes the downregulation of genes
associated with pluripotency or whether this is linked to the
determination of cell commitment.
Here, we quantified the number of mtDNA copies in
undifferentiated mESCs and as they undergo differentiation.
We also determined whether mtDNA replication is a
continuous process during differentiation and whether the
onset of mtDNA replication is related to the pluripotent status
of the cell. We then assessed whether these patterns are
similar in another mESC line or are mESC-line specific.
Finally, we established whether induction of differentiation
by an agent that enriches specific populations of cells
mediates mtDNA replication in a similar manner, and
whether knockdown of Polg alters the pluripotency status of
undifferentiated mESCs.
Results
Loss of pluripotency
In order to determine whether the loss of pluripotency was
associated with the onset of mtDNA replication, we first
analysed the levels of mRNA expression for pluripotency-
associated genes in undifferentiated and spontaneously
differentiating mESCs by real-time reverse transcriptase (RT)-
PCR. During the initial stages of differentiation (day 2), mRNA
expression was significantly upregulated for Dppa5, Pramel7
and Ndp52l1 (Calcoco2) by 1.25-fold (P<0.05), 3.23-fold
(P<0.001) and 21-fold (P<0.001), respectively, when
compared with undifferentiated R1 mESCs (Fig. 1). This was
then followed by a considerable downregulation during days 3
and 4. Dppa5 expression decreased to 4% and 8% of levels for
undifferentiated ESCs (P<0.001) on days 3 and 4, respectively,
whereas Ndp52l1 was undetectable (P<0.001; Fig. 1). Pramel7
expression increased to 7.7-fold compared with
undifferentiated R1 mESCs on day 3 (P>0.05) but was
downregulated to undetectable levels on day 4 (P<0.001).
Apart from day 6, when Dppa5 mRNA expression reached
levels similar to the undifferentiated R1 mESCs, and day 5,
when Pramel7 levels were above those for undifferentiated R1
mESCs (P<0.05), expression of all markers remained very low
or undetectable for the remainder of the culture period (Fig. 1).
The replication of mtDNA
Because the upregulation of mtDNA replication is likely to be
related to the onset of differentiation, we determined whether
there were specific patterns to mtDNA replication during
pluripotency and the early stages of differentiation. To this
extent, mRNA expression for Polg, Polg2 and Tfam, and the
number of mtDNA copies per cell, were analysed in
undifferentiated R1 ESCs and during differentiation. Following
spontaneous differentiation, mRNA expression of Polg was
higher than for undifferentiated R1 mESCs on days 1 (2.7-fold,
P<0.001), 2 (1.3-fold, P<0.01), 5 (2-fold, P>0.05), 8 (4.8-fold,
P<0.001), 11 (1.1-fold, P>0.05) and 12 (4.7-fold, P<0.001;
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Fig. 1. Loss of pluripotency during spontaneous differentiation of R1
mESCs. Expression of the pluripotency-associated genes Dppa5,
Pramel7 and Ndp52l1 was quantified on undifferentiated (Und) and
spontaneously differentiated R1 mESCs (days 1-8) using RT-PCR
relative quantification. Expression of individual genes was compared
with the expression in undifferentiated R1 mESCs and samples were
normalised to Gapdh. Bars represent mean ± s.e.m.; significant
differences between days are indicated (*P<0.05, ***P<0.001).
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Fig. 2B). Similarly, Polg2 was upregulated on days 7 (8.6-fold,
P<0.05), 8 (11.6-fold, P>0.001), 11 (4.3-fold, P<0.001), 12
(4.3-fold, P>0.05) and 13 (2.9-fold, P>0.05; Fig. 2B). As a
result, mtDNA was extensively replicated on days 1, 6 and 11-
13, thus increasing the number of mtDNA copies per cell to
2658 (P<0.001), 7775 (P<0.001) and 10697-14089 (P<0.001),
respectively (Fig. 2A).
At day 3, mtDNA copy number decreased to a minimum of
three copies per cell (P<0.001; Fig. 2A). This coincided with
undetectable levels of Polg and Polg2 mRNA (Fig. 2B).
Despite the significant increase in Polg mRNA expression on
day 8 (P<0.001) and Polg2 transcript levels on days 7 and 8
(P<0.05 and P<0.001, respectively; Fig. 2B), the mtDNA
content of R1 mESCs derived on days 7-9 was similar to
undifferentiated R1 mESCs (Fig. 2A).
Although Tfam mRNA expression was found to be similar to
undifferentiated R1 mESCs at the early stages of differentiation
(day 1 and days 3-5), it was significantly downregulated between
days 6 and 13. During this period, the levels of Tfam expression
varied between 8% (day 6, P<0.001) and 16% (day 7, P<0.001)
of undifferentiated R1 mESCs (Fig. 2B). This decrease in Tfam
expression coincided with an increase in mtDNA replication
(day 6 and days 11-13, P<0.001; Fig. 2A).
In order to determine whether the pattern of mtDNA
replication was characteristic of mESCs, we analysed another
mESC line, D3. In contrast to R1 cells, spontaneously
differentiating D3 cells maintained low levels of mtDNA copy
number until day 6 of differentiation. A general
downregulation of Polg, Polg2 and Tfam mRNA expression
between days 1 to 5 resulted in a significant decrease in
mtDNA copy number when compared with undifferentiated
D3 mESCs (37 copies/cell, P<0.01; Fig. 3A,B). Particularly
low mtDNA content on days 1, 2 and 3 (3, 3 and 1 copies/cell,
respectively; P<0.001; Fig. 3A) coincided with very significant
decreases of Polg (days 2 and 3; P<0.001), Polg2 (days 1 and
2; P<0.001) and Tfam (days 1 and 3; P<0.001) mRNA
expression (Fig. 3B). At day 6, mtDNA copy number
dramatically increased to 2730 copies per cell (P<0.001),
which corresponded to an increase in Polg mRNA expression
similar to those for undifferentiated D3 cells (Fig. 3A,B).
To validate the extensive mtDNA replication taking place on
day 6, undifferentiated and differentiating D3 cells (days 1-7)
were co-labelled with (i) 5-bromo-2-deoxy-uridine (BrdU)
and the mitochondrial-specific label MitoTracker or (ii)
antibodies to the mtDNA-encoded cytochrome c oxidase I
(MT-CO1) and POLG. BrdU and MitoTracker staining were
co-localised and present at all time points studied, indicating
that mtDNA replication was taking place during D3 mESC
differentiation (Fig. 4A). Furthermore, there was increased
BrdU/MitoTracker staining to match the expanded cytoplasm
during differentiation. Days 1-4 had between 14.9% and 26.1%
of cells with an expanded cytoplasm and positive
BrdU/MitoTracker staining, whereas values on days 5, 6 and 7
were 36.5%, 34.8% and 59.3%, respectively (Fig. 4A). In
addition, MT-CO1 and POLG were also colocalised tightly
around the nucleus during days 1-4 (Fig. 4B), but as
differentiation proceeded, both proteins were found in the
expanding cytoplasm, especially at day 6 (Fig. 4B).
Cell fate commitment and mtDNA replication
Because significant mtDNA replication after the loss of
pluripotency did not occur until day 6 of differentiation, we
hypothesised that the onset of differentiation precedes the onset
of mtDNA replication and thus analysed events within the first
7 days of differentiation. This was investigated by determining
whether the onset of lineage-specific markers is coupled to
mtDNA replication, using the D3 mESC line. Dual
immunostaining of vimentin, nestin, -tubulin III
(neuroectoderm markers) and brachyury (mesodermal marker),
with POLG and TFAM was performed on undifferentiated and
spontaneously differentiating D3 mESCs (days 1-7).
Vimentin+, nestin+, -tubulin III+ and brachyury+ D3
mESCs were also positive for POLG and TFAM
(supplementary material Fig. S1A-C). Moreover,
vimentin+/POLG+/TFAM+, nestin+/POLG+/TFAM+, -tubulin
III+/POLG+/TFAM+ (see supplementary material Fig. S1C)
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B Fig. 2. MtDNA copy number/cell and expression of
mtDNA replication factors during spontaneous
differentiation of R1 mESCs (days 1-13). (A) MtDNA
was quantified using real-time PCR and normalised to
the Gapdh gene. The x axis is as in B. (B) Expression
of Polg, Polg2 and Tfam was quantified on
undifferentiated (Und) and spontaneously
differentiated R1 mESCs using RT-PCR relative
quantification. Expression of each gene was compared
with that of the undifferentiated R1 mESCs and
samples were normalised to Gapdh. Bars represent
mean ± s.e.m.; significant differences between days
are indicated (*P<0.05, **P<0.01, ***P<0.001).
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and brachyury+/POLG+/TFAM+ cells were identified up to
day 20 of differentiation. However, the maximum number
of vimentin+/POLG+/TFAM+, nestin+/POLG+/TFAM+ and
brachyury+/POLG+/TFAM+ cells was found on day 3
(15.9±3.7%, P<0.01; 15.2±1.3%, P<0.001; and 11.3±6.5%,
P>0.05, respectively), whereas the proportion of -tubulin
III+/POLG+/TFAM+ cells increased up to day 4 (13.4±1.5%,
P<0.001; supplementary material Fig. S1B). The
vimentin+/POLG+/TFAM+ population was then maintained at
similar levels for the remainder of the differentiation period,
whereas that of nestin+/POLG+/TFAM+ decreased after day 5
(P<0.05; supplementary material Fig. S1B) and -tubulin
III+/POLG+/TFAM+ cells decreased significantly on day 6
(P<0.05; supplementary material Fig. S1B). Indeed, because
the significant increase in mtDNA replication (day 6) occurred
after the downregulation of Dppa5, Pramel7 and Ndp52l1
(days 3 and 4) and after the increase in the proportion of
vimentin+/POLG+/TFAM+, nestin+/POLG+/TFAM+, -tubulin
III+/POLG+/TFAM+ and brachyury+/POLG+/TFAM+ cells
(days 3 and 4), this suggests that definitive lineage
commitment had taken place before substantial changes in
mtDNA replication were initiated.
Induction of differentiation
In order to determine whether targeted induction of
differentiation would affect regulation of mtDNA replication,
we stimulated neuronal differentiation by exposing
undifferentiated D3 mESCs to 10–7 M RA for 2 days following
their introduction into hanging droplets and differentiation
medium. Similar to the spontaneously differentiated D3
mESCs, the vimentin+, nestin+, -tubulin III+ RA-induced D3
mESC were also positive for POLG and TFAM
(supplementary material Fig. S2A-C). The maximum number
of vimentin+/ POLG+/TFAM+ (11.7±1.5%, P<0.001) and
nestin+/POLG+/ TFAM+ (15.3±6.5%, P<0.05) cells were
detected on days 1 and 3, respectively (supplementary material
Fig. S2B). These proportions then decreased with
differentiation, resulting in only 3.6±0.8% of vimentin+/
POLG+/TFAM+ and 5.0±1.6% of nestin+/POLG+/TFAM+ cells
on day 7 (supplementary material Fig. S2B). The proportion
of -tubulin III+/POLG+/TFAM+ RA-induced D3 mESCs
significantly increased to 12.2±1.7% on day 1 (P<0.001) and
were maintained at similar levels until day 7 (supplementary
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Fig. 3. The number of mtDNA copies/cell and expression of mtDNA
replication factors during spontaneous differentiation of D3 mESCs
(days 1-7). (A) The number of mtDNA copies/cell in undifferentiated
(Und) and spontaneously differentiated D3 mESCs was determined
using real-time PCR. The x axis is as in B. (B) The level of Polg,
Polg2 and Tfam expression was quantified using RT-PCR relative
quantification. Expression of individual genes was compared with
the level of expression in undifferentiated D3 mESCs. All samples
were normalised to Gapdh. Bars represent mean ± s.e.m.; significant
differences between days are indicated (*P<0.05, **P<0.01,
***P<0.001).
Fig. 4. Detection and localisation of mtDNA, and of the MT-CO1 and POLG proteins, during spontaneous differentiation of D3 mESCs.
(A) Immunofluorescence analysis of BrdU (red) and MitoTracker (green) on undifferentiated (Und) and spontaneously differentiated D3
mESCs (days 1-7). Percentages represent the proportion of cells with an expanded cytoplasm at each time point. (B) Immunofluorescence
analysis of MT-CO1 (green) and POLG (red) on undifferentiated (Und) and differentiated D3 mESCs (days 1-7). Blue, DNA. Bar, 10 m.
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material Fig. S2B). Although the percentage of nestin+/
POLG+/TFAM+ cells was not significantly different between
the spontaneous differentiated and RA-induced D3 mESCs
(P>0.05), RA stimulation led to a decrease in the proportion
of vimentin+/POLG+/TFAM+ cells on days 2-7 (P<0.05) and
an increase in the percentage of -tubulin III+/POLG+/TFAM+
cells on day 1 (P<0.05).
With the earlier onset of differentiation, it was evident that
RA-induced D3 mESCs had significantly higher levels of Polg
mRNA expression on days 1-4 (P<0.001), and higher levels of
Polg2 and Tfam mRNA expression on days 1-7 (P<0.001), than
their spontaneously differentiated counterparts (Fig. 3B, Fig.
5A,B). This is correlated with an increase in their mtDNA
content between days 1 and 5 (P<0.001; Fig. 3A, Fig. 5A). In
addition, the RA-induced D3 mESCs exhibited more stable
levels of mtDNA copy number than the spontaneously
differentiated D3 mESCs and R1 mESCs. They had 62 mtDNA
copies per cell on day 3 and a minimum of 8 mtDNA copies
per cell on day 7 (P<0.001; Fig. 5A), whereas the
spontaneously differentiated R1 and D3 ESCs had a minimum
of 3 (Fig. 2A) and 1 (Fig. 3A) mtDNA copies per cell on day
3, respectively. Most interestingly, the RA-induced D3 mESCs
also showed a peak for mtDNA content on day 6 (120 mtDNA
copies/cell), which was significantly different to the
undifferentiated D3 mESCs (P<0.001; Fig. 5A). However,
mtDNA copy number in the RA-induced D3 mESCs on day 6
was significantly lower than for R1 (P<0.001; Fig. 2A, Fig.
5A) and D3 (P<0.001; Fig. 3A, Fig. 5A) spontaneously
differentiated mESCs.
POLG knockdown
Real-time RT-PCR of the spontaneously differentiated R1 and
D3 mESCs and the RA-induced D3 mESCs suggested that the
onset of differentiation is associated with significant variations
in the levels of Polg expression (Fig. 2B, Fig. 3B, Fig. 5B). To
evaluate whether steady-state levels of POLG expression are
required to maintain pluripotency, and whether alteration of
those levels are associated with the onset of mESC
differentiation, we used siRNA to knockdown POLG
expression in undifferentiated mESCs. To overcome any
problem with contamination with feeder cells (MEFs), which
could mask POLG knockdown because of the high levels of
the protein, the feeder-free CEE/R mESC line was used.
Densitometry analysis from western blots showed that POLG
levels were decreased by 7.3-fold (Fig. 6) in the
undifferentiated CCE/R mESCs transfected with the Polg
siRNAs when compared with the undifferentiated CCE/R
mESCs transfected with the negative control siRNA. Apart
from the decrease in POLG, OCT4 levels were also decreased
by 2.5-fold (Fig. 6) and brachyury levels increased by 1.2-fold
(Fig. 6) when compared with the negative-control siRNA.
Discussion
Pluripotency and differentiation
Here we have shown that, in R1 mESCs, the pluripotency-
associated genes Dppa5, Pramel7 and Ndp52l1 were
upregulated during days 1 and 2 of differentiation, and
downregulated during days 3 and 4 (Fig. 1). Similarly, the
pluripotency marker OCT4 has been shown to increase
expression by 50% during endodermal differentiation of
mESCs (Niwa et al., 2000). OCT4 expression was also
upregulated during migration and differentiation of the
primitive endoderm into parietal endoderm during mouse-
embryo development (Palmieri et al., 1994), and during RA-
induced differentiation of murine F9 ECCs into visceral and
parietal endodermal cells (Botquin et al., 1998). Furthermore,
days 1 and 2 of mESC differentiation have been shown to be
equivalent to the early post-implantation embryo at the
beginning of gastrulation (E4.5-E6.5) (Leahy et al., 1999) and
therefore high levels of pluripotency-associated gene
expression would be expected. In addition, we have shown that
the percentage of brachyury+/POLG+/TFAM+, vimentin+/
POLG+/TFAM+, nestin+/POLG+/TFAM+ and -tubulin
III+/POLG+/TFAM+ D3 mESCs gradually increased to peak at
days 3 and 4 (supplementary material Fig. S1B). Consistent
with our results, coordinated downregulation of pluripotency-
associated genes and co-expression with lineage-specific
transcription factors has been reported during early stages of
hESC differentiation (Laslett et al., 2007). Consequently, our
data would support the view that a transient increase in the
expression of these pluripotency-associated genes could
initiate a cascade of events leading to the onset of ESC
differentiation and commitment into a specific lineage.
mtDNA replication
Both R1 and D3 undifferentiated mESCs showed low numbers
of mtDNA copies per cell (Fig. 2A, Fig. 3A), with D3 mESCs
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Fig. 5. Effect of RA-induced differentiation on the mtDNA copy
number/cell and expression of Polg, Polg2 and Tfam (days 1-7). 
(A) The number of mtDNA molecules/cell was determined using
real-time PCR and normalised to the Gapdh gene. The x axis is as in
B. (B) Polg, Polg2 and Tfam expression in undifferentiated (Und)
and RA-induced D3 mESCs. RT-PCR relative quantification
compared the expression of individual genes to their expression in
undifferentiated D3 mESCs. Values for each gene were normalised to
Gapdh expression. Bars represent mean ± s.e.m. Significant
differences between undifferentiated and days 1, 3, 4 and 6 are
indicated above the respective bar representing the stage of
differentiation; the significant difference between days 3 and 7 is
shown next to the connecting line (*P<0.05, **P<0.01,
***P<0.001).
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also having low levels of MitoTracker (Fig. 4A) and MT-CO1
(Fig. 4B) staining. This low number of mtDNA copies in
undifferentiated mESCs relates to the requirements of the cell
for high glycolytic metabolism and low oxygen consumption,
which are needed to maintain their proliferative capacity
(Kondoh et al., 2007). Apart from the mtDNA replication peak
on day 1 for R1 mESCs, differentiating R1 and D3 mESCs
maintained low mtDNA copies per cell until day 6 of
differentiation (Fig. 2A, Fig. 3A). This arises because there was
a significant decrease in the transcript levels for Polg on days
3, 4 and 6 (R1 cells; P<0.001) and days 2-4 (D3 cells; P<0.05),
for Polg2 on days 2-6 (R1 cells; P<0.001) and days 1-6 (D3
cells; P<0.01), and for Tfam on day 2 (R1 cells; P<0.01) and
days 1-6 (D3 cells; P<0.05). Indeed, the low levels of BrdU
incorporation into the mtDNA of D3 mESCs during days 1-4
suggest that only basal levels of mtDNA replication were
taking place (Fig. 4A). Moreover, MT-CO1 staining was
located tightly around the nucleus and did not increase to any
great extent during days 1-5 (Fig. 4B). At day 6, both R1 and
D3 mESCs showed a significant increase in mtDNA content
(Fig. 2A, Fig. 3A). D3 mESCs also showed an increase in
BrdU incorporation into mtDNA and in the levels of MT-CO1
(Fig. 4A,B). Furthermore, BrdU incorporation and MT-CO1
were located in expanded cytoplasmic areas, suggesting an
expansion of the cytoplasm and migration of the mitochondria,
as previously reported during mouse and human ESC
differentiation (St John et al., 2005; Cho et al., 2006; Chung et
al., 2007).
Despite upregulation of Polg transcripts on day 8 and Polg2
transcripts on days 7 and 8, R1 mESCs did not replicate
mtDNA to any great extent (Fig. 2A,B). It is possible that this
increase in expression is related to repair of the replicated
mtDNA, because POLG has been shown to replace single-
nucleotide gaps generated by the apurinic/apyrimidinic
endonucleases and release the deoxyribose-phosphate residue
to produce a substrate for the DNA ligase (Graziewicz et al.,
2006). This would be a timely event because the cells from day
7 onwards would already be clearly committed to a specific
lineage and would be precursors of all other lineages within
that pathway. In the foetus, such an event would be crucial to
ensure that a large number of rearrangements did not persist
and lead to the onset of severe mtDNA-type diseases. This
would also be crucial for the continued viability of ESCs,
especially because these are prone to rearrangement as passage
number increases (Maitra et al., 2005).
Interestingly, large levels of mtDNA replication in the R1
mESCs (day 6 and days 11-13, Fig. 2A) coincided with
downregulation of Tfam transcript expression (days 6-13; Fig.
2B). Although increased TFAM expression is normally
associated with an increase in mtDNA transcription and
replication (Montoya et al., 1997; Ekstrand et al., 2004),
several groups have reported that an increase in the number of
TFAM molecules above the optimal mtDNA:TFAM
stoichiometry has inhibitory effects on mtDNA transcription
and replication (Webb and Smith, 1977; Parisi et al., 1993;
Dairaghi et al., 1995; Garstka et al., 2003). Indeed, in certain
circumstances the reduction of TFAM protein levels in human
and Drosophila using RNA interference resulted in increased
mtDNA transcription (Goto et al., 2001; Kanki et al., 2004).
Because TFAM acts as a transcription factor but also binds
mtDNA in a non-specific manner to package the mtDNA
(Alam et al., 2003; Kanki et al., 2004), the decrease of mtDNA
transcription and replication with high levels of TFAM has
been related to extensive packaging of the mtDNA (Shen and
Bogenhagen, 2001). It is likely that condensation of the
mtDNA with high levels of TFAM causes restricted access of
other regulatory proteins. It is therefore possible that
transcription of Tfam during days 1-5 (Fig. 2B) resulted in
accumulation of TFAM protein, whereas large mtDNA
replication events such as those on days 6 and days 11-13 (Fig.
2A) required lower levels of TFAM protein.
mtDNA replication induced by RA
D3 mESCs that were differentiated in the presence of RA
increased the percentage of vimentin+/POLG+/TFAM+ and -
tubulin III+/POLG+/TFAM+ cells more rapidly than
spontaneously differentiated cells (see supplementary material
Fig. S1B, Fig. S2B). Indeed, exposure of 10–7 M RA during
the hanging-droplet stage has previously been shown to
enhance neuronal differentiation of mESCs (Bain et al., 1995;
Fraichard et al., 1995; Strübing et al., 1995; Rohwedel et al.,
1999). Consistent with this, the RA-induced D3 mESCs
showed elevated and more consistent numbers of mtDNA
copy number (days 1-5; Fig. 2A, Fig. 3A, Fig. 5A) than
spontaneously differentiated R1 and D3 mESCs. RA has been
previously reported to upregulate transcription of the mtDNA-
encoded NADH dehydrogenase subunit 5 (mt-Nd5), mt-Co1
and 16S rRNA (mt-Rnr2) (Li et al., 1994; Gaemers et al.,
1998). Upregulation of the mtDNA transcripts is likely to
result from a direct effect of RA on RARE in the mtDNA
(Wrutniak et al., 1995; Demonacos et al., 1996) and RAR in
the mitochondria (Berdanier et al., 2001). Given that POLG
requires an RNA primer to replicate mtDNA (Chang and
Clayton, 1985; Xu and Clayton, 1996), it is possible that the
increase in mtDNA transcription also generated the observed
increases in mtDNA replication. However, the effect of RA on
the mtDNA content might also arise from stimulation of
nuclear genes because higher levels of Polg (days 1-4), Polg2
(days 1-7) and Tfam (days 1-7; Fig. 3B, Fig. 5B) mRNA
expression were detected.
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Fig. 6. The effect of siRNA-mediated knockdown of POLG in
undifferentiated CCE/R mESCs. Pooled cell lysates were prepared
from FACS non-transfected and siRNA-transfected CCE/R. Equal
amounts of protein (100 g) were electrophoresed on a 9% SDS-
PAGE gel then semi-dry blotted onto a polyvinyl difluoride
membrane. The membrane was probed for -actin, POLG, OCT4
and brachyury with the membrane being stripped between each
probing. Lane 1, non-transfected undifferentiated CCE/R mESCs;
lane 2, undifferentiated CCE/R mESCs transfected with negative
control siRNA (75 nM); lane 3, undifferentiated CCE/R mESCs
transfected with siRNA targeting POLG (75 nM); lane 4, human
embryonic kidney cells; lane 5, mouse embryonic fibroblasts.
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The relationship between POLG and pluripotency
During days 1 and 2, spontaneously differentiated R1 and RA-
induced D3 mESCs increased mRNA levels for Polg (Fig. 2B,
Fig. 5B), whereas the spontaneously differentiated D3 mESCs
showed the opposite response (Fig. 3B). This suggests that
defined levels of POLG might be required to maintain
pluripotency and an increase or decrease in such levels could
mediate differentiation of mESCs. Further investigation using
siRNAs to knockdown POLG confirmed that decreased levels
of POLG (7.3-fold; Fig. 6) induced differentiation of CCE/R
mESCs, as demonstrated by a decrease of OCT4 levels (2.5-
fold; Fig. 6) and increased levels of brachyury (1.2-fold; Fig.
6). Supporting this concept, mRNA levels for Polg have been
shown to be dramatically increased at the blastocyst stage of
pre-implantation embryonic development in a range of
mammals (Thundathil et al., 2005; Bowles et al., 2007;
Spikings et al., 2007). At this stage, the majority of cells are
committed to the trophectoderm, in which POLG expression is
likely to be upregulated, whereas the inner cell mass cells
maintain persistently low levels of POLG and continue to be
pluripotent. Furthermore, the alteration of POLG levels seems
to be conserved beyond the mammalian species, because
POLG activity has been shown to increase at the blastula stage
during sea urchin-embryo development (Shioda, 1988).
The association between mtDNA copy number and
differentiation
As previously mentioned, the mtDNA content of both R1 and
D3 spontaneously differentiated mESCs remained minimal
during days 1-5 (Fig. 2A, Fig. 3A). This period coincided with
the downregulation of Dppa5, Pramel7 and Ndp52l1
expression (days 3 and 4; R1 mESCs; Fig. 1) and the
upregulation in the numbers of brachyury+/POLG+/TFAM+,
vimentin+/POLG+/TFAM+, nestin+/POLG+/TFAM+ and -
tubulin III+/POLG+/TFAM+ cells (days 3 and 4; D3 mESCs;
supplementary material Fig. S1B). Although days 1-5 had low
mtDNA content per cell, basal levels of mtDNA replication
were confirmed by incorporation of BrdU into mtDNA (D3
mESCs; Fig. 4A). Low levels of mtDNA replication are most
probably essential in order to replenish the mtDNA content of
proliferating mESCs.
At day 6, when cells had clearly committed to a specific
lineage, mtDNA was extensively replicated (Fig. 2A, Fig. 3A,
Fig. 4A) and mitochondria were detected in wider areas of the
cytoplasm (Fig. 4A,B). Commitment into a specific lineage,
regulated by lineage-specific transcription factors (Pevny et al.,
1998; Brandenberger et al., 2004), is thus likely to initiate the
expansion of the number of mitochondria and mtDNA
molecules per cell according to the specific metabolic demands
of individual cells (Williams, 1986; Moyes et al., 1998).
The dependency of differentiation on oxidative
phosphorylation
Transition from anaerobic metabolism, which characterises
undifferentiated ESCs, into a more efficient mitochondrial,
aerobic metabolism is crucial for successful differentiation of
mouse and human ESCs (St John et al., 2005; Chung et al., 2007;
Kondoh et al., 2007). Activation of the ETC and citric acid cycle
(Krebs cycle) as part of this switch involves an increase in
mtDNA content and expression of proteins involved in aerobic
metabolism and ATP production (St John et al., 2005; Cho et al.,
2006; Chung et al., 2007). Indeed, inhibition of the ETC with
antimycin A or rotenone during mESCs differentiation has been
shown to decrease mitochondrial volume (Spitkovsky et al.,
2004; Chung et al., 2007), whereas disrupted mitochondrial
networks lead to a dramatic reduction in the number of beating
embryoid bodies (EBs; up to 80%) and sarcomere content of
differentiating cardiomyocytes (Chung et al., 2007). Previous
reports suggest that oxidative phosphorylation (OXPHOS) is
activated within the first 7 days of mESC differentiation (Cho et
al., 2006), and our data indicate that this occurs at day 6, perhaps
as a consequence of increased transcriptional activities of the
mtDNA genome, an event that precedes mtDNA replication.
Most interestingly, day 6 of differentiation has been shown to
mirror spatial and temporal expression of lineage-specific
markers that takes place at E7.5 of mouse-embryo development
(Leahy et al., 1999). If day 6 of in vitro mESC differentiation
mimics the molecular events that occur during E7.5, then it is
very likely that the developmental arrest of homozygous Polg
knockout mice between E7.5 and E8.5 (Hance et al., 2005), and
homozygous Tfam knockout mice between E 8.5 and E10.5
(Larsson et al., 1998), was caused by failure to expand the
number of mtDNA molecules per cell, and resulted in aerobic-
respiration deficiency. Indeed, low levels of TFAM, as argued
earlier, would facilitate replication at this time, and thus explain
why TFAM deficiency has a physiological impact later in
development.
We demonstrated that the loss of pluripotency and the
induction of cell fate commitment, upon differentiation of
ESCs, occur in the presence of low levels of mtDNA
replication. We suggest that a decrease in expression of
pluripotency markers and increasing numbers of committed
ESCs proceed in the presence of low levels of expression of
POLG, POLG2 and TFAM, which ensure that sufficient
mtDNA is preserved within proliferating mESCs for
subsequent transmission. After mESCs have committed to a
specific lineage, mtDNA is extensively replicated, leading to
the enrichment of the mitochondrial content to provide the
higher levels of ATP required for further differentiation. We
have shown that the onset of mESC differentiation is associated
with the modulation of Polg expression, and that steady-state
levels of POLG are required to maintain pluripotency. In
addition, RA stimulation led to a more rapid onset of
differentiation and to increased expression of the mtDNA-
specific replication factors, which emphasises that control of
mtDNA copy number is crucial for successful differentiation
of ESCs.
Materials and Methods
Culture of MEFs
Mouse embryonic fibroblasts (MEFs) were cultured in high glucose Dulbecco’s
modified Eagle’s medium (DMEM; Sigma, Gillingham, UK) with 10% foetal
bovine serum (FBS; Sigma), 2 mM L-glutamine (Invitrogen Life Technologies,
Paisley, UK), 1% non-essential amino acids (NEAA; Invitrogen Life Technologies)
and 1% penicillin/streptomycin solution (Sigma). Inactivation of MEFs for use as
mESC feeders was carried out by  irradiation (22.62 grays) or mitomycin C
(Sigma) treatment. Confluent MEFs were treated with mitomycin C (10 g/ml) for
2 hours at 37°C/5% CO2, washed three times with PBS (Sigma) and cultured
overnight or frozen before use as feeder cells for undifferentiated R1 or D3 mESCs.
Culture of mESCs
R1 mESCs (Nagy et al., 1993) were cultured in knockout DMEM with 15% serum
replacement, 1% penicillin/streptomycin solution, 2 mM L-glutamine, 1% NEAA
(all Invitrogen Life Technologies), 0.1 mM -mercaptoethanol (Sigma) and 1000
U/ml leukaemia inhibitory factor (LIF; Chemicon, Temecula, Ca, USA). D3
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(Doetschman et al., 1985) and CCE/R mESCs were cultured in high glucose DMEM
(Sigma) with 15% ESC screened FBS (Hyclone, Utah, US), 1% penicillin/
streptomycin solution (Invitrogen Life Technologies), 2 mM L-glutamine
(Invitrogen Life Technologies), 1% NEAA (Invitrogen Life Technologies), 0.1 mM
-mercaptoethanol (Sigma) and 1000 U/ml LIF.
Differentiation of mESCs
Spontaneous differentiation
Undifferentiated R1 and D3 mESCs were induced to differentiate using the hanging-
drop method (Keller, 1995). Briefly, mESCs (day 0) were dissociated with 0.25%
trypsin-EDTA (Sigma) for 2 minutes, resuspended into mESC medium (minus LIF)
and plated as 20 l droplets (approximately 450 cells per drop) on the lid of an
inverted Petri dish (Sterilin, Staffordshire, UK) for 48 hours (days 1-2) to promote
the formation of EBs. EBs were then placed into suspension for a further 5 (days
3-7, D3 mESCs) or 6 (days 3-8, R1 mESCs) days at 37°C/5%CO2. EBs were then
plated onto gelatin (0.1%; Sigma)-coated six-well plates (Nunc, Roskilde,
Denmark) and cultured up to day 20 of differentiation.
RA-induced differentiation of mESCs (D3)
mESCs were treated as for spontaneous differentiation, except that, during the
hanging-drop stage (days 1-2), RA (10–7 M) was added to the medium.
POLG knockdown
The following FAM-labelled siRNAs (Ambion, Huntingdon, UK) were used: a
negative control siRNA complex with no homology to mouse, rat or human genomes
(supplied by Ambion); and an siRNA complex targeting exons 13 and 14 of Polg
mRNA (siRNA sequence 5-GGACGGUAACAACUACAAUtt-3 and 5-
AUUGUAGUUGUUACCGUCCtt-3). Undifferentiated CCE/R mESCs underwent
transfection with either of the siRNA complexes (75 nM) using Lipofectamine 2000
(Invitrogen Life Technologies), or were not transfected (control), for 24 hours in R1
mESC media (15% knockout serum). After 24 hours, fresh CCE/R media (15%
Hyclone FBS) was added and the cells were maintained in culture for a further 72
hours.
Fluorescent-activated cell sorting (FACS)
All cells were sorted on a MoFlo Cell Sorter (Dakocytomation, Cambridgeshire,
UK) and analysed using the CellQuest/Summit software. Undifferentiated R1 and
D3 mESCs were sorted with the stage-specific embryonic antigen 1 (SSEA-1).
Undifferentiated R1 and D3 mESCs were incubated with 0.25% trypsin-EDTA for
2 minutes, titrated into a single cell suspension and incubated with the SSEA-1
antibody (1:50; Developmental Studies Hybridoma Bank, University of Iowa, USA)
for 30 minutes at 37°C in mESC media plus LIF. The cells were then washed three
times by centrifugation, incubated with the Alexa-Fluor-488 anti-mouse (Molecular
Probes, Paisley, UK) for 30 minutes at 37°C and washed three times by
centrifugation. The SSEA-1-positive R1 and D3 mESCs were then sorted. The
undifferentiated CCE/R cells were washed three times with PBS, trypsinised and
resuspended in CCE/R mESC media 96 hours after transfection. The FAM-labelled
CCE/R and non-transfected cells were sorted.
RNA extraction
Total RNA was extracted from undifferentiated, spontaneously differentiated and
RA-induced (days 1-7) D3 mESCs, and from undifferentiated and spontaneously
differentiated (days 1-13) R1 mESCs. Total RNA was extracted using the
RNAqueous-4PCR kit (Ambion) according to the manufacturer’s instructions.
Samples were treated with DNase I (4 units, Ambion) for 2 hours at 37°C, after
which it was inactivated with DNase inactivation reagent (Ambion). The RNA was
reverse transcribed using the Reverse Transcription System (Promega,
Southampton, UK). Reactions contained 800 ng/l of RNA, 2 l of 10 RT-Buffer,
5 mM of MgCl2, 1 mM of dNTP mixture, 0.25 g Oligo (dT) primer, 1 U/l of
RNasin Ribonuclease Inhibitor, 15 U/g of AMV Reverse Transcriptase and
ultrapure H2O (Sigma) up to 20 l. Reactions were incubated at 42°C for 2 hours
followed by 95°C for 10 minutes to denature the AMV Reverse Transcriptase.
DNA extraction
Total DNA was extracted from undifferentiated, spontaneously differentiated and
RA-induced (days 1-7) D3 mESCs, and undifferentiated and spontaneously
differentiated (days 1-13) R1 mESCs. mESCs (10.0 to 7.5104 cells/l) were
resuspended in ultrapure H2O, freeze-thawed twice and vigorously pipetted to
release DNA into the solution (Lloyd et al., 2006).
Real-time PCR
Each real-time PCR reaction (15 l total volume) contained 2 l of template (cDNA
or DNA), 7.5 l of 2 Sensi Mix (Quantace, London, UK), 0.3 l of 50 SYBR
Green I Solution (Quantace), 0.33 M of each of the forward and reverse primers
(Invitrogen Life Technologies) and ultrapure H2O (Sigma). A 293 bp product of
Dppa5 cDNA was amplified with Dppa 5-F (5-GCTTGATCTCGTCTTCCCTG-
3) and Dppa5-R (5-TCCATTTAGCCCGAATCTTG-3); 336 bp product of
Pramel7 cDNA with Pramel7-F (5-AGAGAACCCACATGGCTTTG-3) and
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Pramel7-R (5-GGATTTGGCTTGGCATACAT-3); 475 bp product of Ndp52l1
cDNA with Ndp52l1-F (5-TTGATGCTCTTGCACAGGAC-3) and Ndp52l1-R
(5-TCACTGTTAGCACTGCCTG-3); 188 bp of Polg cDNA with Polg-F (5-
GGACCTCCCTTAGAGAGGGA-3) and Polg-R (5-AGCATGCCAGCCAG -
AGTCACT-3); 214 bp of Polg2 cDNA with Polg2-F (5-ACAGTGCCTTCAG -
GTTAGTC-3) and Polg2-R (5-ACTCCAATCTGAGCAAGACC-3); 165 bp of
Tfam cDNA with Tfam-F (5-GCATACAAAGAAGCTGTGAG-3) and Tfam-R
(5-GTTATATGCTGAACGAGGTC-3); 366 bp of the Gapdh gene or cDNA with
Gapdh-F (5-GGGAAGCCCATCACCATCTTC-3) and Gapdh-R (5-AGAGG -
GGCCATCCACAGTCT-3); and 211 bp product of the tRNA-Tyr and mt-Co1 genes
of the mtDNA, amplified with tRNA-Tyr/mt-Co1-F (5-CAGTCTA ATGCT -
TACTCAGC-3) and tRNA-Tyr/mt-Co1-R (5-GGGCAGTTACGATAACATTG-
3). Reactions were performed in a Rotorgene-3000 real-time PCR machine
(Corbett Research, Cambridge, UK). Initial denaturation was performed at 95°C for
10 minutes, followed by 50 cycles of: denaturation at 95°C for 10 seconds;
annealing at 53°C (mtDNA and Tfam), 55°C (Polg2) or 60°C (Dppa5, Pramel7,
Ndp52l1, Polg and Gapdh) for 15 seconds; and extension at 72°C for 15 (Polg, Tfam
and mtDNA), 20 (Dppa5, Pramel7 and Polg2), 23 (GAPDH) or 30 (Ndp52l1)
seconds. For the standards, a series of tenfold dilutions (210–2 ng/l to 210–9
ng/l) of the target-specific PCR product were generated.
Data were acquired in the FAM/SYBR channel during the extension phase. In
order to eliminate primer dimerisation from the analysis, a fourth step with data
acquisition was added. The temperature at which the specific product started to melt
was determined using dissociation curves (76°C for mtDNA, 78°C for Polg2 and
Tfam, 81°C for Ndp52l1 or 82°C for Polg and Gapdh) and a second acquisition
phase of 15 seconds in the FAM/Sybr channel was programmed to allow
measurements of fluorescence from specific product only. Melt-curve analysis was
conducted by ramping from 62°C to 99°C (rising 1°C every 5 seconds) and data
were acquired from the FAM/Sybr channel. Analyses were performed using the
Rotor Gene software (version 7; Corbett Research). Each sample was run in
triplicate in two separate reactions generating six readings per gene. From those
values, only the middle four were considered in order to diminish pipetting errors
(Bustin, 2000). Data were expressed as mean ± s.e.m.
The number of mtDNA copies per cell was determined using real-time PCR
absolute quantification. Because samples contained an unknown number of cells,
determination of the number of mtDNA copies per cell required quantification of
the number of Gapdh gene copies and the number of mtDNA copies. The number
of mtDNA copies per cell was calculated using the following formula:
The Pfaffl method of relative expression was used to compare the expression of
Polg, Polg2, Tfam, Dppa5, Pramel7 and Ndp52l1 in differentiating mESCs to the
undifferentiated mESCs (Pfaffl, 2001). This method provides real-time RT-PCR
relative quantification of samples with an unknown number of cells against a
separate reaction for the housekeeping gene (Gapdh).
Immunocytochemistry
Undifferentiated, spontaneously differentiated and RA-induced (days 1-7 and day
20) D3 mESCs were incubated with 0.25% trypsin-EDTA for 2 minutes and titrated
into a single cell suspension. D3 mESCs were then resuspended in D3 mESC
differentiation media (D3 mESC media containing LIF was used for undifferentiated
mESCs), plated onto gelatin-coated coverslips and incubated overnight at
37°C/5%CO2. D3 mESCs were fixed in 2% formaldehyde (Sigma) for 1 hour,
permeabilised for 30 minutes in 1% (v/v) Triton X-100 (Sigma), placed in blocking
solution for at least 30 minutes and incubated with the primary antibodies. MT-CO1
(1:100; Molecular Probes) and the neuroectoderm markers vimentin (1:50; Sigma),
nestin (1:200; BD Pharmingen, Oxford, UK) and -tubulin III (1:100; Sigma) were
co-labelled with the mitochondrial replication factors POLG (1:100; Abcam,
Cambridge, UK) and TFAM (1:200; Santa Cruz Biotechnology, Santa Cruz,
California) by incubating for 2 hours at 37°C. The mesodermal marker brachyury
(1:400; R&D Systems, Abingdon, UK) was co-labelled with POLG and TFAM by
incubating overnight at 4°C. The cells were washed three times with 0.1% Triton
X-100 for 5 minutes at room temperature then incubated with two of 459 anti-rabbit
(POLG and TFAM), 488 anti-mouse (MT-CO1, vimentin, nestin and -tubulin III)
or 488 anti-goat (brachyury) secondary antibody (Molecular Probes) for 1 hour at
37°C. The cells were further washed three times with 0.1% Triton X-100 for 5
minutes and placed onto slides using mounting medium containing DAPI
(Vectashield; Vector Labs, Peterborough, England).
For BrdU and MitoTracker labelling, D3 mESCs were plated onto gelatin-coated
coverslips and incubated overnight in D3 mESC media containing 10 M of BrdU
(Roche Applied Sciences, Sussex, UK) at 37°C/5%CO2. D3 mESCs were then
washed with pre-warmed PBS and incubated with 25 nM MitoTracker (Molecular
Probes) in D3 mESC media for 45 minutes at 37°C/5%CO2. Cultures were fixed
for 15 minutes in 4% formaldehyde and permeabilised in 1% (v/v) Triton X-100
for 15 minutes. D3 mESCs were incubated with recommended concentrations of
the BrdU antibody (1:10, Roche Applied Sciences) and the anti-mouse antibody
(No. of copies of the tRNA-Tyr/mt-Co1 gene)
 MtDNA copies/cell = .
(No. of copies of the Gapdh gene/2) 
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(1:10, Roche Applied Sciences) at 37°C for 30 minutes. A series of three washes
using washing buffer (Roche Applied Sciences) was performed after the antibody
incubations. D3 mESCs were placed onto slides using mounting medium containing
DAPI.
Microscopy and imaging methods
Fluorescent microscopy was performed using a Nikon Eclipse E600 (Nikon, Surrey,
UK). mESCs were visualised using a 40 magnification oil lens and captured on
a Hamamatsu Digital Camera C4742-95. Data were collected using the IPlab 3.7
software (Nikon). For fluorescence microscopy, DAPI was excited at 400 nm and
detected at 420 nm, FITC was excited at 505 nm and detected between 515 and 555
nm, and rhodamine was excited at 595 nm and detected between 600 and 660 nm.
Negative controls were used to determine the appropriate exposure time and prevent
the generation of false positives in the samples.
Western blotting
Cell lysates were prepared from non-transfected and siRNA-transfected sorted
CCE/R cells, human embryonic kidney cells and MEFs. To obtain sufficient protein,
lysates were pooled from separate experiments. Equal amounts of protein (100 g)
were electrophoresed on a 9% SDS-PAGE gel then semi-dry blotted onto a
polyvinyl difluoride membrane by applying a current of approximately 0.8 mA/cm2
of gel for 70 minutes. The membrane was blocked with 5% dried milk powder
(Marvel, Premier Brands, UK) in Tris buffered saline solution (TBS) containing
0.1% Tween 20 (Sigma), for at least 1 hour at room temperature. The membrane
was then probed with antibodies against either -actin (1:10,000; Sigma), POLG
(1:100; Abcam), OCT4 (1:10,000; Abcam) or brachyury (1:250; R&D Systems)
overnight at 4°C. The membrane was washed with TBS/0.1% Tween 20 for 25
minutes with a change of wash solution every 5 minutes. The membrane was probed
with secondary antibodies conjugated with horseradish peroxidase (Vector Labs),
anti-rabbit (1:5000), anti-mouse (1:5000), anti-goat (1:5000) or anti-rabbit (1:5000),
for 1 hour at room temperature. The membrane was washed with TBS/0.1% Tween
20 for 25 minutes with a change of wash solution every 5 minutes and the bands
detected by enhanced chemiluminescence reagent (Perbio Science, Cramlington,
UK). Between probing with each antibody the blot was stripped using Restore
Western Blot Stripping solution (Perbio Science). Densitometry analysis was
performed using ImageJ software (http://rsb.info.nih.gov/ij).
Statistical analysis
One-way ANOVA was used to determine differences in Polg, Polg2 and Tfam
expression, and for mtDNA copy number, in spontaneously differentiated R1 and
D3 mESCs and RA-induced D3 mESCs. Differences in the percentages of 
vimentin-, nestin-, -tubulin III- and brachyury-labelled cells (vimentin+, nestin+,
-tubulin III+ and brachyury+ cells, respectively) during spontaneously
differentiated D3 and RA-induced D3 mESCs, and differences in Dppa5, Pramel7
and Ndp52l1 expression during spontaneous differentiation of R1 mESCs were also
determine by one-way ANOVA. Two-way ANOVA was used to determine
differences in Polg, Polg2 and Tfam expression, mtDNA copy number, and for the
percentages of vimentin+, nestin+, -tubulin III+ and brachyury+ cells between the
spontaneously and RA-induced differentiation protocols. Data were transformed
logarithmically where appropriate. Statistical differences were determined using
unpaired t-tests and groups were considered significantly different when P<0.05.
We thank Dee McLoughlin (Institute of Biomedical Research,
University of Birmingham) for providing the R1 and D3 mESCs and
Laura O’Neill (Institute of Biomedical Research, University of
Birmingham) for providing the CCE/R mESCs. This work was
supported by British Heart Foundation (PG/04/117) and Fundação
para a Ciência e Tecnologia (FCT) Portugal (SFRH/BD/17779/2004).
References
Alam, T. I., Kanki, T., Muta, T., Ukaji, K., Abe, Y., Nakayama, H., Takio, K.,
Hamasaki, N. and Kang, D. (2003). Human mitochondrial DNA is packaged with
TFAM. Nucleic Acids Res. 31, 1640-1645.
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H., Coulson, A. R., Drouin,
J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F. et al. (1981). Sequence and
organisation of the human mitochondrial genome. Nature 290, 457-465.
Bain, G., Kitchens, D., Yao, M., Huettner, J. E. and Gottlieb, D. I. (1995). Embryonic
stem cells express neuronal properties in vitro. Dev. Biol. 168, 342-357.
Berdanier, C. D., Everts, H. B., Hermoyian, C. and Mathews, C. E. (2001). Role of
vitamin A in mitochondrial gene expression. Diabetes Res. Clin. Pract. Suppl. 54, S11-
S27.
Bortvin, A., Eggan, K., Skaletsky, H., Akutsu, H., Berry, D. L., Yanagimachi, R.,
Page, D. C. and Jaenisch, R. (2003). Incomplete reactivation of Oct4-related genes
in mouse embryos cloned from somatic nuclei. Development 130, 1673-1680.
Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M. K., Vriend, G.
and Schöler, H. R. (1998). New POU dimer configuration mediates antagonistic
control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev.
12, 2073-2090.
Bouhon, I. A., Joannides, A., Kato, H., Chandran, S. and Allen, N. D. (2006).
Embryonic stem cell-derived neural progenitors display temporal restriction to neural
patterning. Stem Cells 24, 1908-1913.
Bowles, E. J., Lee, J. H., Alberio, R., Lloyd, R. E., Stekel, D., Campbell, K. H. and
St John, J. C. (2007). Contrasting effects of in vitro fertilisation and nuclear transfer
on the expression of mtDNA replication factors. Genetics 176, 1511-1526.
Brandenberger, R., Wei, H., Zhang, S., Lei, S., Murage, J., Fisk, G. J., Li, Y., Xu,
C., Fang, R., Guegler, K. et al. (2004). Transcriptome characterization elucidates
signaling networks that control human ES cell growth and differentiation. Nat.
Biotechnol. 22, 707-716.
Bustin, S. A. (2000). Absolute quantification of mRNA using real-time reverse
transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169-193.
Carrodeguas, J. A., Theis, K., Bogenhangen, D. F. and Kisker, C. (2001). Crystal
structure and deletion analysis show that the accessory subunit of mammalian DNA
polymerase gamma, Pol gamma B, functions as a homodimer. Mol. Cell 7, 43-54.
Chang, D. D. and Clayton, D. A. (1985). Priming of human mitochondrial DNA
replication occurs at the light-strand promoter. Proc. Natl. Acad. Sci. USA 82, 351-355.
Cho, Y. M., Kwon, S., Pak, Y. K., Seol, H. W., Choi, Y. M., Park, D. J., Park, K. S.
and Lee, H. K. (2006). Dynamic changes in mitochondrial biogenesis and antioxidant
enzymes during the spontaneous differentiation of human embryonic stem cells.
Biochem. Biophys. Res. Commun. 348, 1472-1478.
Chung, S., Dzeja, P. P., Faustino, R. S., Perez-Terzic, C., Behfar, A. and Terzic, A.
(2007). Mitochondrial oxidative metabolism is required for the cardiac differentiation
of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 4, S60-S67.
Clayton, D. A. (1982). Replication of animal mitochondrial DNA. Cell 28, 693-705.
Clayton, D. A. (1992). Transcription and replication of animal mitochondrial DNAs. Int.
Rev. Cytol. 141, 217-232.
Clayton, D. A. (1998). Nuclear-mitochondrial intergenomic communication. Biofactors
7, 203-205.
Dairaghi, D. J., Shadel, G. S. and Clayton, D. A. (1995). Addition of a 29 residue
carboxyl-terminal tail converts a simple HMG box-containing protein into a
transcriptional activator. J. Mol. Biol. 249, 11-28.
Dani, C., Smith, A. G., Dessolin, S., Leroy, P., Staccini, L., Villageois, P., Darimont,
C. and Ailhaud, G. (1997). Differentiation of embryonic stem cells into adipocytes in
vitro. J. Cell Sci. 110, 1279-1285.
Demonacos, C. V., Karayanni, N., Hatzoglou, E., Tsiriyiotis, C., Spandidos, D. A.
and Sekeris, C. E. (1996). Mitochondrial genes as sites of primary action of steroid
hormones. Steroids 61, 226-232.
Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. and Kemler, R. (1985). The
in vitro development of blastocyst-derived embryonic stem cell lines: formation of
visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45.
Drab, M., Haller, H., Bychkow, R., Erdmann, B., Lindschau, C., Haase, H., Morano,
I., Luft, F. C. and Wobus, A. M. (1997). From totipotent embryonic stem cells to
spontaneously contracting vascular smooth muscle cells: a retinoic acid and db-cAMP
in vitro differention model. FASEB J. 11, 905-915.
Ekstrand, M. I., Falkenberg, M., Rantanen, A., Park, C. B., Gaspari, M., Hultenby,
K., Rustin, P., Gustafsson, C. M. and Larsson, N. G. (2004). Mitochondrial
transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet.
13, 935-944.
Fraichard, A., Chassande, O., Bilbaut, G., Dehay, C., Savatier, P. and Samarut, J.
(1995). In vitro differentiation of embryonic stem cells into glial cells and functional
neurons. J. Cell Sci. 108, 3181-3188.
Gaemers, I. C., Van Pelt, A. M., Themmen, A. P. and De Rooij, D. G. (1998). Isolation
and characterization of all-trans-retinoic acid-responsive genes in the rat testis. Mol.
Reprod. Dev. 50, 1-6.
Garstka, H. L., Schmitt, W. E., Schultz, J., Sogl, B., Silakowski, B., Perez-Matos, A.,
Montoya, J. and Wiesner, R. J. (2003). Import of mitochondrial transcription factor
A into rat liver mitochondria stimulates transcription of mitochondrial DNA. Nucleic
Acids Res. 31, 5039-5047.
Goto, A., Matsushima, Y., Kadowaki, T. and Kitagawa, Y. (2001). Drosophila
mitochondrial transcription factor A (d-TFAM) is dispensable for the transcription of
mitochondrial DNA in Kc167 cells. Biochem. J. 354, 243-248.
Gottlieb, D. I. and Huettner, J. E. (1999). An in vitro pathway from embryonic stem
cells to neurons and glia. Cells Tissues Organs 165, 165-172.
Graziewicz, M. A., Longley, M. J. and Copeland, W. C. (2006). DNA polymerase
gamma in mitochondrial DNA replication and repair. Chem. Rev. 106, 383-405.
Hance, N., Ekstrand, M. I. and Trifunovic, A. (2005). Mitochondrial DNA polymerase
gamma is essential for mammalian embryogenesis. Hum. Mol. Genet. 14, 1775-1783.
Herrmann, B. G., Labeit, S., Poustka, A., King, T. R. and Lehrach, H. (1990). Cloning
of the T gene required in mesoderm formation in the mouse. Nature 343, 617-622.
Kanki, T., Ohgaki, K., Gaspari, M., Gustafsson, C. M., Fukuoh, A., Sasaki, N.,
Hamasaki, N. and Kang, D. (2004). Architectural role of mitochondrial transcription
factor A in maintenance of human mitochondrial DNA. Mol. Cell. Biol. 24, 9823-9834.
Keller, G. M. (1995). In vitro differentiation of embryonic stem cells. Curr. Opin. Cell
Biol. 7, 862-869.
Kondoh, H., Lleonart, M. E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D.,
Gil, J. and Beach, D. (2007). A high glycolytic flux supports the proliferative potential
of murine embryonic stem cells. Antioxid. Redox Signal. 9, 293-299.
Lagarkova, M. A., Volchkov, P. Y., Lyakisheva, A. V., Philonenko, E. S. and Kiselev,
S. L. (2006). Diverse epigenetic profile of novel human embryonic stem cell lines. Cell
Cycle 5, 416-420.
Larsson, N. G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M.,
Barsh, G. S. and Clayton, D. A. (1998). Mitochondrial transcription factor A is
necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 18, 231-236.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
4034
Laslett, A. L., Grimmond, S., Gardiner, B., Stamp, L., Lin, A., Hawes, S. M.,
Wormald, S., Nikolic-Paterson, D., Haylock, D. and Pera, M. F. (2007).
Transcriptional analysis of early lineage commitment in human embryonic stem cells.
BMC Dev. Biol. 7, 12.
Leahy, A., Xiong, J., Kuhnert, F. and Stuhlmann, H. (1999). Use of developmental
marker genes to define temporal and spacial patterns of differentiation during embryoid
body formation. J. Exp. Zool. 284, 67-81.
Li, G., Liu, Y. and Tsang, S. S. (1994). Expression of a retinoic acid-inducible
mitochondrial ND5 gene is regulated by cell density in bovine papillomavirus
DNA-transformed mouse C127 cells but not in revertant cells. Int. J. Oncol. 5, 301-
307.
Lim, S. E., Longley, M. J. and Copeland, W. C. (1999). The mitochondrial p55
accessory subunit of the human DNA polymerase gamma enhances DNA binding,
promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J. Biol.
Chem. 274, 38197-38203.
Lloyd, R. E., Lee, J. H., Alberio, R., Bowles, E. J., Ramalho-Santos, J., Campbell,
K. H. and St John, J. C. (2006). Aberrant nucleo-cytoplasmic cross-talk results in
donor cell mtDNA persistence in cloned embryos. Genetics 172, 2515-2527.
Maitra, A., Arking, D. E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui,
G., Cutler, D. J., Liu, Y., Brimble, S. N. et al. (2005). Genomic alterations in cultured
human embryonic stem cells. Nat. Genet. 37, 1099-1103.
Montoya, J., Perez-Matos, A., Garstka, H. L. and Weisner, R. J. (1997). Regulation
of mitochondrial transcription by mitochondrial transcription factor A. Mol. Cell.
Biochem. 174, 227-230.
Morriss-Kay, G. M. and Sokolova, N. (1996). Embryonic development and pattern
formation. FASEB J. 10, 961-968.
Moyes, C. D., Battersby, B. J. and Leary, S. C. (1998). Regulation of muscle
mitochondrial design. J. Exp. Biol. 201, 299-307.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. and Roder, J. C. (1993).
Derivation of completely cell culture-derived mice from early-passage embryonic stem
cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428.
Niwa, H., Miyazaki, J. and Smith, A. G. (2000). Quantitative expression of Oct-3/4
defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24,
372-376.
Palmieri, S. L., Peter, W., Hess, H. and Schöler, H. R. (1994). Oct-4 transcription factor
is differentially expressed in the mouse embryo during establishment of the first two
extraembryonic cell lineages involved in implantation. Dev. Biol. 166, 259-267.
Parisi, M. A. and Clayton, A. (1991). Similarity of human mitochondrial transcription
factor 1 to high mobility group proteins. Science 252, 965-969.
Parisi, M. A., Xu, B. and Clayton, D. A. (1993). A human mitochondrial transcriptional
activator can functionally replace a yeast mitochondrial HMG-box protein both in vivo
and in vitro. Mol. Cell. Biol. 13, 1951-1961.
Pesce, M. and Schöler, H. R. (2001). Oct-4: gatekeeper in the beginnings of mammalian
development. Stem Cells 19, 271-278.
Pevny, L. H., Sockanathan, S., Placzek, M. and Lovell-Badge, R. (1998). A role for
SOX1 in neural determination. Development 125, 1967-1978.
Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res. 29, e45.
Rivolta, M. N. and Holley, C. M. (2002). Asymmetric segregation of mitochondria and
mortalin correlates with the multi-lineage potential of inner ear sensory cell progenitors
in vitro. Brain Res. Dev. Brain Res. 133, 49-56.
Rohwedel, J., Guan, K. and Wobus, A. M. (1999). Induction of cellular differentiation
by retinoic acid in vitro. Cells Tissues Organs 165, 190-202.
Rolletschek, A., Chang, H., Guan, K., Czyz, J., Meyer, M. and Wobus, A. M. (2001).
Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by
survival-promoting factors. Mech. Dev. 105, 93-104.
Shen, E. L. and Bogenhagen, D. F. (2001). Developmentally-regulated packaging of
mitochondrial DNA by the HMG-box protein mtTFA during Xenopus oogenesis.
Nucleic Acids Res. 29, 2822-2828.
Shioda, M. (1988). Subcellular localization of DNA polymerase gamma and changes in
its activity in sea urchin embryos. Comp. Biochem. Physiol. 91B, 525-530.
Shoubridge, E. A. and Wai, T. (2007). Mitochondrial DNA and the mammalian oocyte.
Curr. Top. Dev. Biol. 77, 87-111.
Spikings, E. C., Alderson, J. and St John, J. C. (2007). Regulated mitochondrial DNA
replication during oocyte maturation is essential for successful porcine embryonic
development. Biol. Reprod. 76, 327-335.
Spitkovsky, D., Sasse, P., Kolossov, E., Böttinger, C., Fleischmann, B. K., Hescheler,
J. and Wiesner, R. J. (2004). Activity of complex III of the mitochondrial electron
transport chain is essential for early heart muscle cell differentiation. FASEB J. 18,
1300-1302.
St John, J. C., Ramalho-Santos, J., Gray, H. L., Petrosko, P., Rawe, V. Y., Navara,
C. S., Simerly, C. R. and Schatten, G. P. (2005). The expression of mitochondrial
DNA transcription factors during early cardiomyocyte in vitro differentiation from
human embryonic stem cells. Cloning Stem Cells 7, 141-153.
Strübing, C., Ahnert-Hilger, G., Shan, J., Wiedenmann, B., Hescheler, J. and Wobus,
A. M. (1995). Differentiation of pluripotent embryonic stem cells into the neuronal
lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech. Dev. 53,
275-287.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J.,
Marshall, V. S. and Jones, J. M. (1998). Embryonic stem cell lines derived from
human blastocysts. Science 282, 1145-1147.
Thundathil, J., Filion, F. and Smith, L. C. (2005). Molecular control of mitochondrial
function in preimplantation mouse embryos. Mol. Reprod. Dev. 71, 405-413.
Wallace, D. C. (1999). Mitochondrial diseases in man and mouse. Science 283, 1482-
1488.
Webb, A. C. and Smith, L. D. (1977). Accumulation of mitochondrial DNA during
oogenesis in Xenopus laevis. Dev. Biol. 56, 219-225.
Wilkinson, D. G., Bhatt. S. and Herrmann, B. G. (1990). Expression pattern of the
mouse T gene and its role in mesoderm formation. Nature 343, 657-659.
Williams, R. S. (1986). Mitochondrial gene expression in mammalian striated muscle.
Evidence that variation in gene dosage is the major regulatory event. J. Biol. Chem.
261, 12390-12394.
Wrutniak, C., Cassar-Malek, I., Marchal, S., Rascle, A., Heusser, S., Keller, J. M.,
Fléchon, J., Dauça, M., Samarut, J., Ghysdael, J. et al. (1995). A 43-kDa protein
related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. J. Biol.
Chem. 270, 16347-16354.
Xu, B. and Clayton, D. A. (1995). A persistent RNA-DNA hybrid is formed during
transcription at a phylogenetically conserved mitochondrial DNA sequence. Mol. Cell.
Biol. 15, 580-589.
Xu, B. and Clayton, D. A. (1996). RNA-DNA hybrid formation at the human
mitochondrial heavy-strand origin ceases at replication start sites: an implication for
RNA-DNA hybrids serving as primers. EMBO J. 15, 3135-3143.
Journal of Cell Science 120 (22)
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
